Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated December 28, 2021.

Cadila: Unfolding vaccine opportunity can offset US headwinds

For a longer term play, Cadila has a promising pipeline for NCEs (New chemical entities), biosimilars and injectables

Buy Cadila Healthcare target of Rs 695: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 695 in its research report dated dated August 24, 2021.

Buy Cadila Healthcare; target of Rs 720: Sharekhan

Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated August 11, 2021.

Cadila: Vaccine opportunity unfolds

On conservative basis, for COVID vaccine opportunity, Cadila can at least add 16 per cent of FY21 sales revenue, on a full-year basis

Buy Cadila Healthcare; target of Rs 670: Motilal Oswal

Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 11, 2021.

Cadila: More a COVID hedge in the near term

Cadila's India presence -- at about 45 per cent of sales -- is similar in size as the US business and provides better cash-flow visibility

Hold Cadila Healthcare; target of Rs 640: ICICI Direct

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 640 in its research report dated May 28, 2021.

Buy Cadila Healthcare: target of Rs 720: Sharekhan

Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 27, 2021.

Buy Cadila Healthcare; target of Rs 740: Motilal Oswal

Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 740 in its research report dated May 28, 2021.

Buy Cadila Healthcare; target of Rs 701: Dolat Capital Market

Dolat Capital Market is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 701 in its research report dated May 28, 2021.

Accumulate Cadila Healthcare; target of Rs 678: Arihant Capital

Arihant Capital recommended Accumulate rating on Cadila Healthcare with a target price of Rs 678 in its research report dated May 28, 2021.

Accumulate Cadila Healthcare target of Rs 696: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Cadila Healthcare with a target price of Rs 696 in its research report dated May 28, 2021.

Cadila: All in for COVID while keeping a tab on complex pharma

Cadila's stock has been primed by a series of potential rollouts to meet the COVID challenge

Weekly Tactical Pick | Cadila Healthcare

COVID opportunity and traction in complex pharma pipeline are big positives for Cadila

Buy Cadila Healthcare; target of Rs 655: Emkay Global Financial

Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report dated March 24, 2021.

Buy Cadila Healthcare; target of Rs 550: Motilal Oswal

Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 550 in its research report dated February 06, 2021.

Buy Cadila Healthcare; target of Rs 555: ICICI Direct

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated February 06, 2021.

Cadila: COVID vaccine to be the key differentiator in the near term

In the next fiscal, Cadila plans to launch 40-plus products, including 8-10 complex molecules which should offset pricing erosion

Buy Cadila Healthcare; target of Rs 655: Emkay Global Financial

Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report dated January 22, 2021.

COVID Vaccine: The opportunities for investors - Part I

Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation

Accumulate Cadila Healthcare; target of Rs 497: Dolat Capital Market

Dolat Capital Market recommended accumulate rating on Cadila Healthcare with a target price of Rs 497 in its research report dated November 02, 2020.

Buy Cadila Healthcare; target of Rs 555: ICICI Direct

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated November 03, 2020.

Sell Cadila Healthcare; target of Rs 357: Prabhudas Lilladher

Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 357 in its research report dated November 03, 2020.

Buy Cadila Healthcare: target of Rs 530: Sharekhan

Sharekhan is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 530 in its research report dated November 03, 2020.